Linezolid extracorporeal removal during haemodialysis with high cut-off membrane in critically ill patients

International Journal of Antimicrobial Agents

Volumn 46, Issue 4, 2015, Pages 465-468

  Villa, Gianluca ^a   Cassetta, Maria Iris ^a   Tofani, Lorenzo ^a   Valente, Serafina ^b   Chelazzi, Cosimo ^a   Falsini, Silvia ^a   De Gaudio, Angelo Raffaele ^a   Novelli, Andrea ^a   Ronco, Claudio ^c   Adembri, Chiara ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c SAN BORTOLO HOSPITAL   (Italy)

Author keywords

High cut off membrane; High performance liquid chromatography; Linezolid; Pharmacodynamics; Pharmacokinetics; Sepsis

Indexed keywords

LINEZOLID; ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CASE REPORT; CONTINUOUS HEMODIALYSIS; CONTINUOUS VENOVENOUS HEMODIALYSIS WITH HIGH CUT OFF MEMBRANE; CRITICAL ILLNESS; DIALYSATE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INFUSION; EFFLUENT; HUMAN; MALE; MAXIMUM PLASMA CONCENTRATION; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MINIMUM PLASMA CONCENTRATION; PHARMACODYNAMICS; PRIORITY JOURNAL; SEPSIS; VERY ELDERLY; VOLUME OF DISTRIBUTION; CHEMICALLY INDUCED; COMPLICATION; KIDNEY FAILURE; MICROBIAL SENSITIVITY TEST; PROCEDURES; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; HUMANS; LINEZOLID; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY; SEPSIS;

EID: 84948579702     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.06.015     Document Type: Article

References (13)

1. Cardinal-Fernández P, Ferruelo A, El-Assar M, Santiago C, Gómez-Gallego F,Martín-Pellicer A, et al. Genetic predisposition to acute kidney injury inducedby severe sepsis. J Crit Care 2013;28:365-70.
2. Oh HJ, Shin DH, Lee MJ, Koo HM, Doh FM, Kim HR, et al. Early initiation ofcontinuous renal replacement therapy improves patient survival in severe pro-gressive septic acute kidney injury. J Crit Care 2012;27:e9-18.
3. Carcelero E, Soy D, Guerrero L, Poch E, Fernandez J, Castro P, et al. Linezolidpharmacokinetics in patients with acute renal failure undergoing continuousvenovenous hemodiafiltration. J Clin Pharmacol 2012;52:1430-5.
4. Smuszkiewicz P, Szalek E, Tomczak H, Grzéskowiak E. Continuous infusion ofantibiotics in critically ill patients. Curr Clin Pharmacol 2013;8:13-24.
5. Zoller M, Maier B, Hornuss C, Neugebauer C, Döbbeler G, Nagel D, et al. Variabil-ity of linezolid concentrations after standard dosing in critically ill patients: aprospective observational study. Crit Care 2014;18:R148.
6. Drusano GL. Antimicrobial pharmacodynamics: critical interactions of 'bug anddrug'. Nat Rev Microbiol 2004;2:289-300.
7. Villa G, Zaragoza JJ, Sharma A, Neri M, De Gaudio AR, Ronco C. Cytokine removalwith high cut-off membrane: review of literature. Blood Purif 2014;38:167-73.
8. Caldini A, Chelazzi C, Terreni A, Biagioli T, Giannoni C, Villa G, et al. Is procal-citonin a reliable marker of sepsis in critically ill septic patients undergoingcontinuous veno-venous hemodiafiltration with 'high cut-off' membranes(HCO-CVVHDF)? Clin Chem Lab Med 2013;51:261-3.
9. Adembri C, Fallani S, Cassetta MI, Arrigucci S, Ottaviano A, Pecile P, et al. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septicpatients: intermittent versus continuous infusion. Int J Antimicrob Agents2008;31:122-9.
10. MacGowan AP. Pharmacokinetic and pharmacodynamic profile of linezolid inhealthy volunteers and patients with Gram-positive infections. J AntimicrobChemother 2003;51(Suppl. 2):ii17-25.
11. Kraft M, Pasko D, DePestel D, Ellis J, Peloquin C, Mueller B. Linezolid clearanceduring continuous venovenous hemodiafiltration: a case report. Pharma-cotherapy 2013;23:1071-5.
12. Morabito S, Guzzo I, Vitaliano E, Muzi L, Solazzo A, Pistolesi V, et al. Princi-ples of pharmacokinetics and dose adjustment of drugs in continuous renalreplacement therapies (CRRT) [in Italian]. G Ital Di Nefrol 2006;23:127-38.
13. De Pascale G, Fortuna S, Tumbarello M, Cutuli SL, Vallecoccia M, Spanu T,et al. Linezolid plasma and intrapulmonary concentrations in critically ill obesepatients with ventilator-associated pneumonia: intermittent vs continuousadministration. Intensive Care Med 2014;41:103-10.